Monika got her PhD with the greatest mark. CONGRATULATION!
Her PhD dealt with the human tRNA methyl transferase TRMT2A, its function and its properties as drug target against poly-glutamine disorders, such as Huntington's disease. Her work will hopefully submitted soon for publication.
Monika already moves on as a postdoc to the lab of Schraga Schwartz at the Weizmann Institute in Israel.